Clinical Trials in Detroit

Showing 11661-11680 of 16,931 trials

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

NCT01818388

A multicenter prospective single arm interventional trial in hospitals where therapeutic hypothermia is standard practice. This trial will enroll 50 subjects to evaluate the ability of the ZOLL Intravascular Temperature Management (IVTM) System to induce, maintain, and reverse mild therapeutic hypothermia and maintain normothermia post cardiac arrest.

Out of Hospital Cardiac Arrest

ZOLL Circulation, Inc., USA50 participantsStarted Jul 2014

New Britain, Connecticut, United States • Detroit, Michigan, United States • Royal Oak, Michigan, United States +6 more locations

COMPLETEDPhase 2< 1 mile

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

NCT01985126

The purpose of this study is to evaluate the efficacy and safety of 2 daratumumab treatment regimens in participants with multiple myeloma who have received at least 3 prior lines of therapy (including a proteasome inhibitor \[PI\] and immunomodulatory drug \[IMiD\]) or are double refractory to a PI and an IMiD.

Multiple Myeloma

Janssen Research & Development, LLC124 participantsStarted Sep 2013

Duarte, California, United States • Los Angeles, California, United States • Atlanta, Georgia, United States +20 more locations

COOL-ARREST Pilot Study to Assess Intravascular Temperature Management (IVTM) in the Treatment of Cardiac Arrest

An Efficacy and Safety Study of Daratumumab in Patients With Multiple Myeloma Who Have Received at Least 3 Prior Lines of Therapy (Including a Proteasome Inhibitor [PI] and Immunomodulatory Drug [IMiD]) or Are Double Refractory to a PI and an IMiD

Find Trials by Condition in Detroit

Study to Assess the Immune Reactivity of the Liquid and Lyophilized Formulations of Palivizumab (MEDI-493, Synagis)

A Comparator Study of Fluticasone Propionate Nasal Spray Verses (vs) Cetirizine in the Treatment of Seasonal Allergic Rhinitis

Gefitinib in Treating Patients With Recurrent or Progressive CNS Tumors

Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor

Randomized Trial Comparing Stereotactic Body Radiation Therapy to Microwave Ablation for the Treatment of Localized Hepatocellular Carcinoma

Non-Invasive Neurostimulation for the Prevention of Chronic Migraine

Measuring the Impact of MammaPrint on Adjuvant and Neoadjuvant Treatment in Breast Cancer Patients: A Prospective Registry

Acute Study to Collect Electrical Signals From the Heart Using a Special Lead

Safety and Tolerability Study of ISIS EIF4E Rx in Combination With Carboplatin and Paclitaxel

A Safety Study of Intravenous Pro-Netupitant and Palonosetron Combination for the Prevention of Nausea and Vomiting

Follow-up Study to Evaluate the Safety and Immunogenicity of a HPV Vaccine (580299) in North America

VenaSeal Sapheon Closure System Pivotal Study (VeClose)

A Post-approval LAP-BAND® Lower Body Mass Index (LBMI) Study

Safety, Tolerability and Efficacy of ISIS-GCGRRx in Patients With Type 2 Diabetes

Innovative Tool to Increase Completion of Human Papillomavirus (HPV) Vaccine Series

A Study Evaluating the Safety and Pharmacokinetics of DMUC4064A in Participants With Platinum-Resistant Ovarian Cancer or Unresectable Pancreatic Cancer

Pilot Evaluation of a New Galyfilcon A Lens Prototype and Enfilcon A Lens

Sub-optimal Response to Anti-Tumor Necrosis Factor's in Inflammatory Bowel Disease in Emerging Markets